Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2014-RN-01253-1
Product Name/Description EPIQ5 Vi .0.x/1 .1 .x with QLAB a2DQ and/or aCMQ plug-ins

ARTG Number: 100468
Recall Action Level Hospital
Recall Action Classification Class I
Recall Action Commencement Date 27/11/2014
Responsible Entity Philips Electronics Australia Ltd
Reason/Issue When using the EPIQ5 Ultrasound System with QLAB Auto 2D Quantification (a2DQ) and Auto Cardiac Motion DESCRIPTION Quantification (aCMQ) applications to calculate End-Systolic Volume (ESV), the reported ESV may be smaller than ESV calculated by manual tracing without the use of EPIQ5 Ultrasound System with QLAB. Correspondingly, the Left Ventricular Ejection Fraction (EF) calculated using these applications may be higher than the EF calculated by manual tracing without the use of EPIQ5 Ultrasound System with QLAB. Philips’ investigation has found that this difference may occur in cases where the EF is less than approximately 40%.
Recall Action Recall for Product Correction
Recall Action Instructions Philips is providing instructions to assist end users to determine if they are affected by this issue. Philips has developed a software update to correct the issue. A CD with the new version of the software will be sent to all end users for installation.

Until the software has been upgraded, the issue can be avoided by ensuring that left ventricular volumes and ejection fraction are calculated by using either the on-cart manual analysis package or off-cart manual analysis package for your primary assessment. This action has been closed-out on 05/08/2016.
Contact Information 1800 251 400 - Philips Customer Care Centre